Casaevades el tema

Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment

Por um escritor misterioso
Last updated 23 janeiro 2025
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Biomedicines, Free Full-Text
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Acquired resistance for immune checkpoint inhibitors in cancer
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Molecules, Free Full-Text
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Reversin 121, a P-glycoprotein Inhibitor, Reverses P-glycoprotein
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Understanding and targeting resistance mechanisms in cancer - Lei
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Frontiers Recent Progress of Novel Nanotechnology Challenging
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Phytochemicals reverse P-glycoprotein mediated multidrug
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Emerging nanotechnology-based therapeutics to combat multidrug
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
List of the known P-gp substrates and inhibitors.
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Approaches to minimize the effects of P‐glycoprotein in drug
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Theoretical insights on helix repacking as the origin of P
Recomendado para você
você pode gostar

© 2014-2025 likytut.eu. All rights reserved.